BIORELEASE CORP
S-8, 2000-01-26
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: OCCIDENTAL PETROLEUM CORP /DE/, 8-K, 2000-01-26
Next: DREYFUS PREMIER NEW YORK MUNICIPAL BOND FUND, NSAR-B, 2000-01-26





                             REGISTRATION STATEMENT

                                      UNDER

                           THE SECURITIES ACT OF 1933

                                 BIORELEASE CORP
              -----------------------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                                             88-0218411
- -------------------------------                     ----------------------------
(State or other jurisdiction of                     (I. R. S. Employment Number)
 incorporation or organisation)

               CONSULTANT STOCK OPTIONS DATED JANUARY 17, 2000 FOR

                                  ROBERT B TODD
                               ------------------
                              (Full title of Plan)

       R. BRUCE REEVES 340 GRANITE STREET, SUITE 200, MANCHESTER, NH 03102
       -------------------------------------------------------------------
                     (Name and Address of Agent for Service)

                                 (603) 641-8443
          ------------------------------------------------------------
          (Telephone number including area code, of agent for service)

                         CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>

                        Proposed Maximum Proposed Maximum

Title of Securities      Amount to be     Maximum Offering    Aggregate Offering
To be Registered        Registered (1)    Price per Share        Offering Price
- --------------------------------------------------------------------------------
<S>                        <C>               <C>                 <C>
Common Stock (1)           100,000           $ 0.11              $ 11,000.00

</TABLE>

(1)  The amount represents an aggregate of 100,000 shares of Common Stock, to be
     issued for services rendered to the Company.

















                                      -1-

<PAGE>

         PART I.  INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

Item 1.  Plan (s) Information.

         The  information  required in Part I includes  letter  agreement  dated
January 17, 2000 representing services to be rendered for shares in the Company.

         PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

         The  Registrant  is  subject  to the  information  requirements  of the
Securities Exchange Act of 1934 and, in accordance therewith, files reports with
the Securities and Exchange Commission ("The Commission").  The documents listed
below are hereby  incorporated  by reference in this  Registration  Statement on
form S-8; and all documents  subsequently  filed by the  Registrant  pursuant to
Section 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a
post-effective  amendment which indicates that all securities  offered have been
sold or which de-registers all securities and remaining unsold,  shall be deemed
to be incorporated  herein by reference in this  Registration  Statement on Form
S-8, and shall be a part hereof from the date of the filings of such documents.

(a)      The Registrant's annual report on Form 10-KSB for the fiscal year ended
         June 30, 1999 and

(b)      All other reports filed by the Registrant  pursuant to Section 13(a) or
         15(d) of the Exchange Act since June 30, 1999 and

(c)      The  description  of  the  Common  Stock,  which  is  contained  in the
         registration  statement  filed under the Exchange  Act,  including  any
         amendment   or  report,   filed  for  the  purpose  of  updating   such
         description.

Item 4.  Description of Securities

         Not applicable.

Item 5.  Interest of Named Experts and Counsel

         The validity of the authorisation and issuance of the Common Stock will
be passed upon by John B. Lowy,  P. C.,  Suite 403,  645 Fifth Avenue 4th Floor,
New York, New York 10022.






                                      -2-

<PAGE>

Item 6.  Indemnification of Directors and Officers

Section  145 of  the  Delaware  General  Corporation  Law  empowers  a  Delaware
corporation to indemnify any person who is, or is threatened to be made, a party
to any  threatened,  pending or completed  action,  suit or  preceding,  whether
civil, criminal,  administrative or investigative (other than an action by or in
the right of such  corporation) by reason of the fact that such person is or was
an officer or director of such corporation,  or is or was serving at the request
of such  corporation  as a  director,  officer,  employee  or agent  or  another
corporation  or  enterprise.  The  indemnity  may  include  expenses  (including
attorney's fees), judgements,  fines and amounts paid in settlement actually and
reasonably  incurred by such person in  connection  with such  action,  suite or
proceeding,  provided  that he acted in good faith and in a manner he reasonably
believed to be in or not opposed to the best interest of the  corporation,  and,
with respect to any criminal  action or proceeding,  has no reasonable  cause to
believe his conduct was unlawful.  A Delaware corporation may indemnify officers
and directors in an action by or in the right of the corporation  under the same
conditions,  except  that  no  indemnification  is  permitted  without  judicial
approval if the officer or director is adjudged to be liable for  negligence  or
misconduct in the performance of his duty to the corporation. Here an officer or
director is  successful  on the merits or otherwise in the defense of any action
referred to above;  the  corporation  must  indemnify  him against the expenses,
which  he  actually  and  reasonably  incurred  in  connection  therewith.   The
indemnification  provided is not deemed to be  exclusive  of any other rights to
which an officer or director may be entitled under a corporation's  by-laws,  an
agreement, vote or otherwise.

         Section 102(b)(7) of the Delaware General  Corporation Law, as amended,
permits a corporation  to provide in its  certificate  of  incorporation  that a
director of the corporation shall not be personally liable to the corporation or
its  stockholders  for  monetary  damages  for  breach  of  fiduciary  duty as a
director,  except for  liability  (I) for any breach of the  director's  duty of
loyalty to the corporation or its  stockholders,  (ii) for acts of omissions not
in good faith or which involve intentional  misconduct or a knowing violation of
law, (iii) under Section 174 of the Delaware  General  Corporation  Law, or (iv)
for any  transaction  from  which the  director  derived  an  improper  personal
benefit.

         Article EIGHT of the  Registrant's  Certificate  of  Incorporation,  as
amended, sets forth the extent to which directors and officers of the Registrant
may be indemnified  against  liabilities which they incur in their capacities as
directors  or officers  of the  Registrant.  Article  EIGHT also  provides  that
director  or the  Registrant  shall  not be  liable  to  the  Registrant  or its
stockholders  for monetary damages for breach of fiduciary duty as a director to
the  fullest  extent  such  limitation  is  permitted  by the  Delaware  General
Corporation Law.

Article V of the Company's By-laws provides as follows:

The  corporation  shall  indemnify  any and all of its  Directors or Officers or
former Directors or Officers or any person who may have served at its request as
a Director or Officer of another  corporation in which it owns shares of capital
stock or of which it is a creditor  against  expenses  actually and  necessarily
incurred  by  them  in  connection  with  the  defense  of any  action,  suit or
proceeding in which they, or any of them, are made party,  or they, by reason of
being or having  been  Directors  of  Officers  or a Director  or Officer of the
corporation, or of such other corporation,  except, in relation to matters as to
which any such Director or Officer or former Director or Officer or person shall
be adjudged in such action,  suits or proceedings to be liable for negligence or
misconduct, in the performance of duty. Such indemnification shall not be deemed
exclusive  by any others'  rights to which those  indemnified  may be  entitled,
under By-law, agreement, vote of stockholder or otherwise.

Item 7.  Exemption from Registration Claimed

         Not applicable.


                                      -3-
<PAGE>

Item 8.  Exhibits

4.1      Certificate of Incorporation of the Registrant (1)

4.2      Amendment to Certificate of  Incorporation  of the Registrant  changing
         the name of the Corporation to Biorelease Corp. (1)

4.3      By-laws, as amended, of the Registrant (1)

                  OTHER EXHIBITS

4.4      The letter dated January 17, 2000 from the law office of Robert B. Todd
         describing the services to be performed for stock registered hereunder.


4.5      Minutes of Board Meeting dated January 19, 2000  regarding the issuance
         and registration of these shares.

- --------------------------
(1)      Previously  filed with the Commission as an Exhibit to the Registrant's
         Registration  Statement on Form S-1, as amended, File No. 33-43976 that
         was originally filed with the Commission November 14, 1991.

Item 9.  Undertakings

1.       The undersigned  Registrant hereby undertakes to file during any period
         in which offers or sales are being made, a post-effective  amendment to
         this  Registration  Statement to include any material  information with
         respect to the plan of  distribution  not  previously  disclosed in the
         Registration  Statement or any material  change to such  information in
         the Registration Statement.

2.       The undersigned  Registrant  hereby undertakes that, for the purpose of
         determining  any liability  under the Securities Act of 1933, each such
         post-effective  amendment  shall  be  deemed  to be a new  registration
         statement  relating to the securities  offered therein and the offering
         of such  securities at that time shall be deemed to be the initial bona
         fide offering thereof.

3.       The   undersigned   Registrant   hereby   undertakes   to  remove  from
         registration  by  means  of  a  post-effective  amendment  any  of  the
         securities  being  registered which remain unsold at the termination of
         the offering.







                                      -4-
<PAGE>

4.       The  undersigned  Registrant  hereby  undertakes  that for  purposes of
         determining  any liability  under the  Securities  Exchange Act of 1934
         that is incorporated by reference in the  registration  statement shall
         be deemed to be a new registration  statement related to the securities
         offered therein, and the offering of such securities at such time shall
         be deemed to be the initial bona fide offering thereof.

5.       Insofar as indemnification of liabilities  arising under the Securities
         Act of 1933 may be permitted to directors,  officers,  and  controlling
         persons of the  Registrant  pursuant to the  foregoing  provisions,  or
         otherwise,  the  Registrant  has been  advised  in the  opinion  of the
         Securities  and Exchange  Commission  such  indemnification  is against
         public policy as expressed in the Act and is, therefore, unenforceable.
         In the event that a claim for indemnification  against such liabilities
         (other than the payment by the Registrant of expenses  incurred or paid
         by a director,  officer or controlling  person of the Registrant in the
         successful  defense of any action,  suit or  proceeding) is asserted by
         such  director,  officer or controlling  person in connection  with the
         securities being registered, the Registrant will, unless in the opinion
         of its counsel the matter has been  settled by  controlling  precedent,
         submit to a court of appropriate jurisdiction the question whether such
         indemnification  by it is against public policy as expressed in the Act
         and will be governed by the final adjudication of such issue.





















                                      -5-
<PAGE>

                                   SIGNATURES

         Pursuant to the  requirements  of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the registrant certifies that it has reasonable grounds to
believe  that it meets all of the  requirements  for  filing on Form S-8 and has
duly caused this  registration  statement on Form S-8 to be signed on its behalf
by the undersigned,  thereunto duly authorised, in Manchester, New Hampshire, on
the date set forth below.

                                          BIORELEASE CORP.
Dated: January 24, 2000                   By:  /s/ Richard F. Schubert
                                               -----------------------
                                               Richard F. Schubert, Chairman

         Pursuant  to the  requirements  of the  Securities  Act of  1933,  this
registration  statement has been signed below by the following persons on behalf
of the Company and in the capacities and on the dates indicated.

<TABLE>
<CAPTION>

SIGNATURES                            TITLE                               DATE

<S>                           <C>                                         <C>
/s/ R. Bruce Reeves           President and Principal Executive           January 24, 2000
- -------------------
R. Bruce Reeves               Officer and Director


/s/ Kevin T. McGuire          Treasurer and Principal Financial and       January 24, 2000
- --------------------
Kevin T. McGuire


/s/ Richard Whitney           Director                                    January 24, 2000
- -------------------
Richard Whitney

</TABLE>



             MINUTES OF A SPECIAL MEETING OF THE BOARD OF DIRECTORS

                                       OF

                                BIORELEASE CORP.

Upon previous  notice to all Directors of the Corporation and at the call of the
Chairman,  Richard Schubert, the Board of Directors of Biorelease Corp. convened
by teleconference at approximately 10:30 AM, January 19, 2000. On the phone were
Directors Whitney and Schubert along with Dr. Reeves,  President of the Company,
who  placed  the  call at the  request  of the  Chairman.  Dr.  Reeves  acted as
Secretary, Pro Tem for the meeting.

Mr. Schubert asked Dr Reeves to report on the recent recision order by the Texas
Court relating to the longstanding Genesis matter. After each Director had had a
chance to ask further questions, it was

         VOTED to ratify the Texas Court  recision order  effective  January 13,
         2000 of the  Genesis  transaction  of March 31,  1994  relating  to the
         previous issue of 1.5 million shares in the Company,  thereby canceling
         the 1.5 million shares previously issued to Genesis,  currently held by
         Genesis (1.4 million shares) and William E. Bowers (100,000 shares).

         FURTHER to reissue to RT Robertson  Consultants  or assigns 1.5 million
         new  shares,  as such have  been  committed  under the Asset  Agreement
         effective June 30, 1999.  Such reissued shares shall be reissued in the
         following denominations and to the following parties:

                  50,000 restricted shares (single  certificate) to be issued to
                  US Benefits Trust

                  100,000  unrestricted  shares to be issued to Robert B.  Todd,
                  all shares to be registered on Form S-8 for services  provided
                  to the Company.

                  100,000  restricted  shares  to  be  issued  to  RT  Robertson
                  Consultants,  Inc. to replace certificate originally issued to
                  Genesis   and   subsequently   transferred   to   Wm.   Bowers
                  (Certificate  # 59635),  such to be reissued  upon receipt and
                  cancellation of original certificate from Bowers.

                  1,250,000  restricted  shares  to be  issued  to RT  Robertson
                  Consultants, Inc. in a single certificate.

Mr.  Schubert  then  asked  Dr.  Reeves  to  update  the  Board  about the Polar
transaction.  Reeves explained that both the S-4 and S-1 draft registrations had
been reviewed by Counsel and the Auditor and were ready for release.  After each
Director was given the opportunity to ask questions and make comments, it was

         VOTED to  authorize  Dr.  Reeves  to file  Form S-4 & S-1  registration
         documents with SEC relating to the Polar  transaction  and the spin off
         of the Subsidiary.

<PAGE>

         FURTHER to set the record date for the  stockholder  meeting to approve
         the Polar  transaction as well as for the spin off of the Subsidiary at
         March 15, 2000.

There being no further  business to come  before the Board,  the  teleconference
meeting was adjourned at approximately 10:45 AM.





/s/ R. Bruce Reeves
- --------------------------------------
R. Bruce Reeves, Secretary Pro tem




                                 LAW OFFICE OF
                                 ROBERT B. TODD
                                P.O. BOX 460251

                                                             TEL: (713) 783-5993
                                                             FAX: (713) 783-5994
- --------------------------------------------------------------------------------

DATE: January 17, 2000
FROM: Robert B. Todd
TO: Bruce Reeves/Biorelease Corp.
FAX NUMBER: (603) 641-9535
NUMBER OF PAGES INCLUDING THIS PAGE: 1

Re: Genesis Capital matter:

Dear Bruce:

Pursuant to our telephone  conversation  of earlier  today,  I will undertake to
perform legal  services in connection  with the claim  against  Genesis  Capital
Corporation and Genesis Capital  Corporation of Nevada.  The fee, as agreed,  is
your conveyance to me of 100,000 shares of common stock of Biorelease Corp.

Call or fax if you have any questions.

Thank,

Robert B. Todd



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission